Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1977 Jan;15(1):19–25. doi: 10.1128/iai.15.1.19-25.1977

Stable L-Forms of Clostridium perfringens: Growth, Toxin Production, and Pathogenicity

D E Mahony 1
PMCID: PMC421324  PMID: 188763

Abstract

Growth and toxin production of stable L-forms of Clostridium perfringens grown in a mini-fermentor were monitored. A gradual but steady increment in viable count occurred over a 7-h period, followed by death. The peak of viability preceded the optical density peak by 3 h. Theta, alpha, kappa, and lambda toxins were measured, with theta toxin appearing first in the culture supernate. Growth of the parent bacillus form of C. perfringens was compared under similar conditions. Toxin levels achieved by the bacillus culture exceeded those of the L-form culture four- to eightfold; however, based upon viable count, the L-form organism produced 8 to 16 times as much toxin as did the bacillus. The amounts of extracellular toxin produced by both forms were similar when related to cell protein rather than cell number. Guinea pig inoculation showed that the L-form of C. perfringens did not produce gas gangrene, although it was not entirely without effect. Both guinea pig and human sera were inhibitory to these L-forms, a fact attributable to a heat-liable component in the sera, most likely complement.

Full text

PDF
22

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BULLEN J. J., CUSHNIE G. H. Experimental gas gangrene: the effect of antiserum on the growth of Clostridium welchii type A. J Pathol Bacteriol. 1962 Jul;84:177–192. doi: 10.1002/path.1700840119. [DOI] [PubMed] [Google Scholar]
  2. Drach G., Schmitt-Slomska J. Incidence of cellular and humoral factors on group A streptococcal L forms. II. Killing effect of sera and phagocytic cells. Ann Microbiol (Paris) 1973 Dec;124(4):463–476. [PubMed] [Google Scholar]
  3. KAWATOMARI T. Studies of the L-forms of Clostridium perfringens. I. Relationship of colony morphology and reversibility. J Bacteriol. 1958 Sep;76(3):227–232. doi: 10.1128/jb.76.3.227-232.1958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Louria D. B. L forms, spheroplasts and aberrant forms in chronic sepsis. Adv Intern Med. 1971;17:125–142. [PubMed] [Google Scholar]
  5. Mahony D. E., Moore T. I. Stable L-forms of Clostridium perfringens and their growth on glass surfaces. Can J Microbiol. 1976 Jul;22(7):953–959. doi: 10.1139/m76-138. [DOI] [PubMed] [Google Scholar]
  6. OYAMA V. I., EAGLE H. Measurement of cell growth in tissue culture with a phenol reagent (folin-ciocalteau). Proc Soc Exp Biol Med. 1956 Feb;91(2):305–307. doi: 10.3181/00379727-91-22245. [DOI] [PubMed] [Google Scholar]
  7. SCHEIBEL I., ASSANDRI J. Isolation of toxigenic L-phase variants from Cl. tetani. Acta Pathol Microbiol Scand. 1959;46:333–338. doi: 10.1111/j.1699-0463.1959.tb01103.x. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES